XINXF yields 1.51% · PFE yields 6.13%● Live data
📍 XINXF pulled ahead of the other in Year 1
Combined, XINXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XINXF + PFE for your $10,000?
New Work SE operates professional networking platforms in Germany and internationally. It operates through B2C, B2B E-Recruiting, and B2B Marketing Solutions & Events segments. The B2C segment serves XING members who use xing.com, XING Jobs, and kununu.com or internations.org to network with other professionals for finding a suitable job, obtaining information about employers, or reading about career-related topics. The B2B E-Recruiting segment products portfolio includes Job ads (XJM), XING TalentManager (XTM), XING TalentPoolManager (XTP), XING Talent Referral Manager (XRM), Employee branding profile, Prescreen Applicant Tracking System, XING TalentService (XTS), XING 360 package, and Honeypot. This segment serves customers who seek access to employees and talent. The B2B Marketing Solutions & Events segment offers native, video, and content advertising formats, sponsored mailings, audience network, and event subsegment, as well as ticketing solutions. This segment serves advertising and events clients. The company was formerly known as Xing SE and changed its name to New Work SE in August 2019. The company was founded in 2003 and is based in Hamburg, Germany. New Work SE is a subsidiary of Burda Digital SE.
Full XINXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.